Longitudinal metabolite profiling of Streptococcus pneumoniae-associated community-acquired pneumonia.

Community-acquired pneumonia High-dimensional data Longitudinal data Metabolomics Personalized medicine

Journal

Metabolomics : Official journal of the Metabolomic Society
ISSN: 1573-3890
Titre abrégé: Metabolomics
Pays: United States
ID NLM: 101274889

Informations de publication

Date de publication:
05 Mar 2024
Historique:
received: 14 07 2023
accepted: 17 01 2024
medline: 6 3 2024
pubmed: 5 3 2024
entrez: 5 3 2024
Statut: epublish

Résumé

Longitudinal biomarkers in patients with community-acquired pneumonia (CAP) may help in monitoring of disease progression and treatment response. The metabolic host response could be a potential source of such biomarkers since it closely associates with the current health status of the patient. In this study we performed longitudinal metabolite profiling in patients with CAP for a comprehensive range of metabolites to identify potential host response biomarkers. Previously collected serum samples from CAP patients with confirmed Streptococcus pneumoniae infection (n = 25) were used. Samples were collected at multiple time points, up to 30 days after admission. A wide range of metabolites was measured, including amines, acylcarnitines, organic acids, and lipids. The associations between metabolites and C-reactive protein (CRP), procalcitonin, CURB disease severity score at admission, and total length of stay were evaluated. Distinct longitudinal profiles of metabolite profiles were identified, including cholesteryl esters, diacyl-phosphatidylethanolamine, diacylglycerols, lysophosphatidylcholines, sphingomyelin, and triglycerides. Positive correlations were found between CRP and phosphatidylcholine (34:1) (cor = 0.63) and negative correlations were found for CRP and nine lysophosphocholines (cor = - 0.57 to - 0.74). The CURB disease severity score was negatively associated with six metabolites, including acylcarnitines (tau = - 0.64 to - 0.58). Negative correlations were found between the length of stay and six triglycerides (TGs), especially TGs (60:3) and (58:2) (cor = - 0.63 and - 0.61). The identified metabolites may provide insight into biological mechanisms underlying disease severity and may be of interest for exploration as potential treatment response monitoring biomarker.

Identifiants

pubmed: 38441696
doi: 10.1007/s11306-024-02091-5
pii: 10.1007/s11306-024-02091-5
pmc: PMC10914916
doi:

Substances chimiques

C-Reactive Protein 9007-41-4
Biomarkers 0
Triglycerides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

35

Informations de copyright

© 2024. The Author(s).

Références

Eur J Pharm Sci. 2017 Nov 15;109S:S15-S21
pubmed: 28502671
Sci Rep. 2018 Aug 17;8(1):12365
pubmed: 30120318
Respir Res. 2018 Jan 03;19(1):1
pubmed: 29295703
PLoS One. 2014 Feb 24;9(2):e89728
pubmed: 24586991
Crit Care. 2020 Jul 27;24(1):461
pubmed: 32718333
PLoS One. 2019 May 7;14(5):e0216379
pubmed: 31063483
Respir Res. 2022 Jan 4;23(1):1
pubmed: 34983515
Thorax. 1996 Oct;51(10):1010-6
pubmed: 8977602
Metabolomics. 2021 Mar 11;17(3):31
pubmed: 33704583
Redox Biol. 2022 Dec;58:102556
pubmed: 36459717
Int J Mol Sci. 2019 Apr 24;20(8):
pubmed: 31022834
Clin Pharmacol Ther. 2021 Aug;110(2):346-360
pubmed: 33559152
Metabolites. 2019 May 17;9(5):
pubmed: 31108909
Intensive Care Med. 2013 Aug;39(8):1423-34
pubmed: 23673400
Clin Chem Lab Med. 2019 Mar 26;57(4):442-451
pubmed: 30183665
Amino Acids. 2009 May;37(1):1-17
pubmed: 19301095
Arch Intern Med. 2002 Mar 25;162(6):682-8
pubmed: 11911722
J Nutr. 2001 Oct;131(10):2772S-2774S
pubmed: 11584104
PLoS One. 2021 Jun 4;16(6):e0252378
pubmed: 34086721

Auteurs

Ilona den Hartog (I)

Division of Systems Pharmacology & Pharmacy, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.

Laura B Zwep (LB)

Division of Systems Pharmacology & Pharmacy, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.

Jacqueline J Meulman (JJ)

LUXs Data Science, Leiden, The Netherlands.
Department of Statistics, Stanford University, Stanford, CA, USA.

Thomas Hankemeier (T)

Metabolomics Centre, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.

Ewoudt M W van de Garde (EMW)

Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
Department of Clinical Pharmacy, St. Antonius Hospital, Nieuwegein, The Netherlands.

J G Coen van Hasselt (JGC)

Division of Systems Pharmacology & Pharmacy, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands. coen.vanhasselt@lacdr.leidenuniv.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH